These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2235202)

  • 21. Leads from the MMWR. Assessing exposures of health-care personnel to aerosols of ribavirin--California.
    JAMA; 1988 Oct; 260(13):1844-5. PubMed ID: 3418843
    [No Abstract]   [Full Text] [Related]  

  • 22. Aerosol consensus statement. Consensus Conference on Aerosol Delivery.
    Chest; 1991 Oct; 100(4):1106-9. PubMed ID: 1914568
    [No Abstract]   [Full Text] [Related]  

  • 23. Occupational exposure to ribavirin aerosols.
    Lancet; 1988 Oct; 2(8617):976. PubMed ID: 2902429
    [No Abstract]   [Full Text] [Related]  

  • 24. [International trends in the control of occupational hazards of exposure to chemical agents].
    Parmeggiani L
    Med Lav; 1978; 69(3):189-94. PubMed ID: 45735
    [No Abstract]   [Full Text] [Related]  

  • 25. Occupational exposure to aerosolized pentamidine.
    Montgomery AB; Corkery KJ; Brunette ER; Leoung GS; Waskin H; Debs RJ
    Chest; 1990 Aug; 98(2):386-8. PubMed ID: 2376170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced environmental exposure to aerosolized ribavirin using a simple containment system.
    Torres A; Krilov LR; Jacobson JM; Kelly KJ; Havens PL
    Pediatr Infect Dis J; 1991 Mar; 10(3):217-21. PubMed ID: 2041670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse reactions to ribavirin.
    Hunt-Fugate A; Murray DL
    Pediatr Infect Dis J; 1990 Sep; 9(9):680-1. PubMed ID: 2235197
    [No Abstract]   [Full Text] [Related]  

  • 28. Occupational exposures to aerosolized pharmaceuticals and control strategies.
    Decker JA; Seitz TA; Shults RA; Deitchman S; Tucker SP; Belinky BR; Clark NJ
    Scand J Work Environ Health; 1992; 18 Suppl 2():100-2. PubMed ID: 1514061
    [No Abstract]   [Full Text] [Related]  

  • 29. ["When should a substance be designated as sensitizing for the skin ("sh") or for the airways ("sa")"?"].
    Schnuch A; Lessmann H; Schulz KH; Becker D; Diepgen TL; Drexler H; Erdmann S; Fartasch M; Greim H; Greim H; Kricke-Helling P; Merget R; Merk H; Nowak D; Rothe A; Stropp G; Uter W; Wallenstein G
    Pneumologie; 2002 May; 56(5):304-8. PubMed ID: 12089648
    [No Abstract]   [Full Text] [Related]  

  • 30. [Occupational diseases of the nervous system caused by chemicals].
    Triebig G
    Dtsch Med Wochenschr; 2006 Dec; 131(50):2825-6. PubMed ID: 17160763
    [No Abstract]   [Full Text] [Related]  

  • 31. Outfitted to filter out respiratory risk.
    Christy EJ
    Occup Health Saf; 1993 Sep; 62(9):62-3, 66, 69-72. PubMed ID: 8414372
    [No Abstract]   [Full Text] [Related]  

  • 32. Monumental hazards.
    Seixas NS
    Ann Occup Hyg; 2014 Jan; 58(1):2-5. PubMed ID: 24371042
    [No Abstract]   [Full Text] [Related]  

  • 33. Occupational exposure to glutaraldehyde.
    Campbell M; Beach JR
    Occup Med (Lond); 1994 Jul; 44(3):165-6. PubMed ID: 7919304
    [No Abstract]   [Full Text] [Related]  

  • 34. The exposure of health care workers to ribavirin aerosol.
    JAMA; 1989 Oct; 262(14):1947-8. PubMed ID: 2778925
    [No Abstract]   [Full Text] [Related]  

  • 35. Occupational atropine poisoning via aerosol.
    Larkin GL
    Lancet; 1991 Apr; 337(8746):917. PubMed ID: 1672993
    [No Abstract]   [Full Text] [Related]  

  • 36. Precautions in the use of ribavirin at the children's hospital.
    Fackler JC; Flannery K; Zipkin M; McIntosh K
    N Engl J Med; 1990 Mar; 322(9):634. PubMed ID: 2304514
    [No Abstract]   [Full Text] [Related]  

  • 37. Design and evaluation of a ribaviran aerosol administration system.
    Piepenbrink JC; Cullen JI; Chipman D
    Biomed Instrum Technol; 1991; 25(6):436-40. PubMed ID: 1777765
    [No Abstract]   [Full Text] [Related]  

  • 38. Health care worker exposure to aerosolized ribavirin: biological and air monitoring.
    Shults RA; Baron S; Decker J; Deitchman SD; Connor JD
    J Occup Environ Med; 1996 Mar; 38(3):257-63. PubMed ID: 8882097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerosol dispersion during various respiratory therapies: a risk assessment model of nosocomial infection to health care workers.
    Hui DS; Chan MT; Chow B
    Hong Kong Med J; 2014 Aug; 20 Suppl 4():9-13. PubMed ID: 25224111
    [No Abstract]   [Full Text] [Related]  

  • 40. [Risk factors and pathogenesis of occupational asthma].
    Pałgan K; Dziedziczko A
    Pol Merkur Lekarski; 2003 Jan; 14(79):62-4. PubMed ID: 12712833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.